Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.

@article{Pushko2007EvaluationOI,
  title={Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.},
  author={Peter Pushko and Terrence M. Tumpey and Neal S Van Hoeven and Jessica A. Belser and Robin A Robinson and Margret Nathan and Gale Smith and Danaya C. Wright and Rick A. Bright},
  journal={Vaccine},
  year={2007},
  volume={25 21},
  pages={4283-90}
}
The development of safe and effective vaccines for avian influenza viruses is a priority for pandemic preparedness. Adjuvants improve the efficacy of vaccines and may allow antigen sparing during a pandemic. We have previously shown that influenza virus-like particles (VLPs) comprised of HA, NA, and M1 proteins represent a candidate vaccine for avian… CONTINUE READING